T1	Participants 62 108	peripheral stage IA non-small cell lung cancer
T2	Participants 213 260	phase III multi-centre randomised trial (ROSEL)
T3	Participants 1013 1151	a planning study was performed in 26 stage I patients, of which 22 were stage 1A, in order to develop and evaluate the planning guidelines
